Key result
IL-6 knockout prevented Angiotensin II-induced hypertension (MAP 126 vs 149 mm Hg in wild-type) but did not mediate the Angiotensin II-induced decrease in total renal blood flow.
Answers are grounded in this paper and cite their sources.
IL-6 knockout prevents Angiotensin II-induced hypertension through a mechanism that involves the renal JAK2/STAT3 pathway but is independent of total renal blood flow reduction.
Chronic angiotensin II (Ang II) infusion stimulates interleukin (IL) 6 release, and we and others have shown that preventing the increase in IL-6 significantly attenuates Ang II hypertension. This study measured renal blood flow (RBF) chronically, using Transonic flow probes in wild-type (WT) and IL-6 knockout (KO) mice, to determine the role of RBF regulation in that response. Ang II infusion at 200, 800, and 3600 ng/kg per minute caused a dose-dependent decrease in RBF in WT mice, and the response at 800 ng/kg per minute was compared between WT and IL-6 KO mice. Ang II infusion increased plasma IL-6 concentration in WT mice and increased mean arterial pressure (19 h/d with telemetry) from 113±4 to 149±4 mm Hg (Δ36 mm Hg) over the 7-day infusion period, and that effect was blocked in IL-6 KO mice (119±7 to 126±7 mm Hg). RBF decreased to an average of 61±8% of control over the 7-day period (control: 0.86±0.02 mL/min) in the WT mice; however, the average decrease to 72±6% of control (control: 0.88±0.02 mL/min) in the KO mice was not significantly different. There also was no difference in afferent arteriolar constriction by Ang II in blood-perfused juxtamedullary nephrons in WT versus KO mice. Phosphorylation of janus kinase 2 and signal transducer and activator of transcription 3 in renal cortex homogenates increased significantly in Ang II-infused WT mice, and that effect was prevented completely in Ang II-infused IL-6 KO mice. These data suggest that IL-6-dependent activation of the renal janus kinase 2/signal transducer and activator of transcription 3 pathway plays a role in Ang II hypertension but not by mediating the effect of Ang II to decrease total RBF.
No takes yet. Share an insight, caveat, or question.
Brands et al. (2010) studied Angiotensin II Hypertension. IL-6 knockout vs. Wild-type mice was evaluated on Mean arterial pressure and renal blood flow. IL-6 knockout prevented Angiotensin II-induced hypertension (MAP 126 vs 149 mm Hg in wild-type) but did not mediate the Angiotensin II-induced decrease in total renal blood flow.
Synapse has enriched 10 related papers. Consider them for comparative context: